These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16327731)

  • 21. Novel human pathological mutations. Gene symbol: Zmpste24. Disease: Restrictive dermopathy.
    Saxena R; Kohli S; Verma IC
    Hum Genet; 2010 Apr; 127(4):480. PubMed ID: 21488301
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetic basis of lipodystrophies and management of metabolic complications.
    Agarwal AK; Garg A
    Annu Rev Med; 2006; 57():297-311. PubMed ID: 16409151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restrictive dermopathy in a Turkish newborn.
    Yesil G; Hatipoglu L; Esteves-Vieira V; Levy N; De Sandre-Giovannoli A; Tüysüz B
    Pediatr Dermatol; 2011; 28(4):408-11. PubMed ID: 21121943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prelamin A processing and functional effects in restrictive dermopathy.
    Columbaro M; Mattioli E; Schena E; Capanni C; Cenni V; Levy N; Navarro CL; Del Coco R; Squarzoni S; Camozzi D; Hutchison CJ; Wehnert M; Lattanzi G
    Cell Cycle; 2010 Dec; 9(23):4766-8. PubMed ID: 21127399
    [No Abstract]   [Full Text] [Related]  

  • 25. RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome.
    Gruber J; Lampe T; Osborn M; Weber K
    J Cell Sci; 2005 Feb; 118(Pt 4):689-96. PubMed ID: 15671064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A newly identified splice site mutation in ZMPSTE24 causes restrictive dermopathy in the Middle East.
    Sander CS; Salman N; van Geel M; Broers JL; Al-Rahmani A; Chedid F; Hausser I; Oji V; Al Nuaimi K; Berger TG; Verstraeten VL
    Br J Dermatol; 2008 Sep; 159(4):961-7. PubMed ID: 18671782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel frameshifting mutations of the ZMPSTE24 gene in two siblings affected with restrictive dermopathy and review of the mutations described in the literature.
    Smigiel R; Jakubiak A; Esteves-Vieira V; Szela K; Halon A; Jurek T; Lévy N; De Sandre-Giovannoli A
    Am J Med Genet A; 2010 Feb; 152A(2):447-52. PubMed ID: 20101687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complex case study: nursing care of an infant with restrictive dermopathy.
    Bosque E
    J Perinat Neonatal Nurs; 2009; 23(2):171-7. PubMed ID: 19474589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restrictive dermopathy--a lethal congenital laminopathy. Case report and review of the literature.
    Morais P; Magina S; Ribeiro Mdo C; Rodrigues M; Lopes JM; Thanh Hle T; Wehnert M; Guimarães H
    Eur J Pediatr; 2009 Aug; 168(8):1007-12. PubMed ID: 19020898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome.
    Mallampalli MP; Huyer G; Bendale P; Gelb MH; Michaelis S
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14416-21. PubMed ID: 16186497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focal segmental glomerulosclerosis in patients with mandibuloacral dysplasia owing to ZMPSTE24 deficiency.
    Agarwal AK; Zhou XJ; Hall RK; Nicholls K; Bankier A; Van Esch H; Fryns JP; Garg A
    J Investig Med; 2006 May; 54(4):208-13. PubMed ID: 17152860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Falling apart.
    Davenport RJ
    Sci Aging Knowledge Environ; 2005 Jun; 2005(26):nf52. PubMed ID: 15994212
    [No Abstract]   [Full Text] [Related]  

  • 33. Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors.
    Rusiñol AE; Sinensky MS
    J Cell Sci; 2006 Aug; 119(Pt 16):3265-72. PubMed ID: 16899817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24.
    Corrigan DP; Kuszczak D; Rusinol AE; Thewke DP; Hrycyna CA; Michaelis S; Sinensky MS
    Biochem J; 2005 Apr; 387(Pt 1):129-38. PubMed ID: 15479156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A-type lamins and progeroïd syndromes : persistent farnesylation with dramatic effects].
    Navarro CL; Poitelon Y; Lévy N
    Med Sci (Paris); 2008 Oct; 24(10):833-40. PubMed ID: 18950579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autosomal recessive LMNA mutation causing restrictive dermopathy.
    Youn GJ; Uzunyan M; Vachon L; Johnson J; Winder TL; Yano S
    Clin Genet; 2010 Aug; 78(2):199-200. PubMed ID: 20662858
    [No Abstract]   [Full Text] [Related]  

  • 37. The laminopathies: a clinical review.
    Rankin J; Ellard S
    Clin Genet; 2006 Oct; 70(4):261-74. PubMed ID: 16965317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained accumulation of prelamin A and depletion of lamin A/C both cause oxidative stress and mitochondrial dysfunction but induce different cell fates.
    Sieprath T; Corne TD; Nooteboom M; Grootaert C; Rajkovic A; Buysschaert B; Robijns J; Broers JL; Ramaekers FC; Koopman WJ; Willems PH; De Vos WH
    Nucleus; 2015; 6(3):236-46. PubMed ID: 25996284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A shared founder mutation underlies lethal restrictive dermopathy in the Austronesian aboriginal Atayal tribe of Taiwan.
    Hou JW
    J Formos Med Assoc; 2015 Oct; 114(10):1017-9. PubMed ID: 25260550
    [No Abstract]   [Full Text] [Related]  

  • 40. LMNA, ZMPSTE24, and LBR are not mutated in scleroderma.
    Gaudy-Marqueste C; Boyer A; Navarro C; Rouzier C; Harley JR; Weiller PJ; Grob JJ; Levy N; De Sandre-Giovannoli A
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):635-9. PubMed ID: 19645629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.